Search research articles
Contact Us
Filters
Showing results (111-120 of 149) with videos related to
Page
of 15
Sort By:
Alimentary Pharmacology & Therapeutics
|
February 22, 2007
Programme of stepping down from twice daily proton pump inhibitor therapy for symptomatic gastro-oesophageal reflux disease associated with a formulary change at a VA medical center
G A Coté, M R Ferreira, K Rozenberg-Ben-Dror, et al.
The American Journal of Gastroenterology
|
June 13, 1998
Changing trends in esophageal cancer: a 15-year experience in a single center
V K Sharma, H Chockalingam, C A Hornung, et al.
The American Journal of Gastroenterology
|
October 1, 1991
Comparison of different measurements of intestinal permeability in inflammatory bowel disease
C W Howden, C Robertson, A Duncan, et al.
Gut
|
July 1, 1988
Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist
D B Jones, C W Howden, D W Burget, et al.
The American Journal of Gastroenterology
|
May 1, 1997
Nonencapsulated, intact omeprazole granules effectively suppress intragastric acidity when administered via a gastrostomy
V K Sharma, E J Heinzelmann, E N Steinberg, et al.
European Journal of Clinical Pharmacology
|
January 1, 1993
The consequences of H2 receptor antagonist--piroxicam coadministration in patients with joint disorders
P A Milligan, P E McGill, C W Howden, et al.
Alimentary Pharmacology & Therapeutics
|
September 18, 2014
Editorial: healing of refractory reflux oesophagitis--an ongoing unmet clinical need; authors' reply
P J Kahrilas, T Persson, H Denison, et al.
The American Journal of Gastroenterology
|
June 23, 2001
The utility of urgent colonoscopy in the evaluation of acute lower gastrointestinal tract bleeding: a 2-year experience from a single center
T L Angtuaco, S K Reddy, S Drapkin, et al.
Alimentary Pharmacology & Therapeutics
|
August 18, 2009
Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis - maintenance of healing and symptom relief
C W Howden, L M Larsen, M C Perez, et al.
Alimentary Pharmacology & Therapeutics
|
August 30, 2008
Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers
N Elnachef, J M Scheiman, A M Fendrick, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 149) with videos related to
Sort By:
Page
of 15
Alimentary Pharmacology & Therapeutics
|
February 22, 2007
Programme of stepping down from twice daily proton pump inhibitor therapy for symptomatic gastro-oesophageal reflux disease associated with a formulary change at a VA medical center
G A Coté, M R Ferreira, K Rozenberg-Ben-Dror, et al.
The American Journal of Gastroenterology
|
June 13, 1998
Changing trends in esophageal cancer: a 15-year experience in a single center
V K Sharma, H Chockalingam, C A Hornung, et al.
The American Journal of Gastroenterology
|
October 1, 1991
Comparison of different measurements of intestinal permeability in inflammatory bowel disease
C W Howden, C Robertson, A Duncan, et al.
Gut
|
July 1, 1988
Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist
D B Jones, C W Howden, D W Burget, et al.
The American Journal of Gastroenterology
|
May 1, 1997
Nonencapsulated, intact omeprazole granules effectively suppress intragastric acidity when administered via a gastrostomy
V K Sharma, E J Heinzelmann, E N Steinberg, et al.
European Journal of Clinical Pharmacology
|
January 1, 1993
The consequences of H2 receptor antagonist--piroxicam coadministration in patients with joint disorders
P A Milligan, P E McGill, C W Howden, et al.
Alimentary Pharmacology & Therapeutics
|
September 18, 2014
Editorial: healing of refractory reflux oesophagitis--an ongoing unmet clinical need; authors' reply
P J Kahrilas, T Persson, H Denison, et al.
The American Journal of Gastroenterology
|
June 23, 2001
The utility of urgent colonoscopy in the evaluation of acute lower gastrointestinal tract bleeding: a 2-year experience from a single center
T L Angtuaco, S K Reddy, S Drapkin, et al.
Alimentary Pharmacology & Therapeutics
|
August 18, 2009
Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis - maintenance of healing and symptom relief
C W Howden, L M Larsen, M C Perez, et al.
Alimentary Pharmacology & Therapeutics
|
August 30, 2008
Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers
N Elnachef, J M Scheiman, A M Fendrick, et al.
Page
of 15